Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants

Ashley David Otter, Silvia D’Arcangelo, Heather Whitaker, Jacqueline Hewson, Sarah Foulkes, Ana Atti, Michelle Cole, Ezra Linley, Simon Tonge, Nipunadi Hettiarachchi, Noshin Sajedi, Davina Calbraith, Chris Norman, Elen de Lacy, Lesley Price, Sally Stewart, Lisa Cromey, Diane Corrigan, SIREN study group, Cathy Rowe, Colin S Brown, Jasmin Islam, Amanda Semper, Susan Hopkins, Victoria Hall, Tim Brooks
doi: https://doi.org/10.1101/2022.04.21.22274025

Data Availability

Annotated code for this analysis is available at: (https://github.com/SIREN-study/SARS-CoV-2-Immunity). The metadata for this analysis will be available to researchers through the Health Data Research UK CO-CONNECT platform and available for secondary analysis.

https://github.com/SIREN-study/SARS-CoV-2-Immunity

Back to top
Posted April 21, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants
Ashley David Otter, Silvia D’Arcangelo, Heather Whitaker, Jacqueline Hewson, Sarah Foulkes, Ana Atti, Michelle Cole, Ezra Linley, Simon Tonge, Nipunadi Hettiarachchi, Noshin Sajedi, Davina Calbraith, Chris Norman, Elen de Lacy, Lesley Price, Sally Stewart, Lisa Cromey, Diane Corrigan, SIREN study group, Cathy Rowe, Colin S Brown, Jasmin Islam, Amanda Semper, Susan Hopkins, Victoria Hall, Tim Brooks
medRxiv 2022.04.21.22274025; doi: https://doi.org/10.1101/2022.04.21.22274025
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area